Free Trial
→ Out of 18,347 Cryptocurrencies... This is the ONLY One (From Crypto 101 Media) (Ad)tc pixel Free ORKA Stock Alerts

Oruka Therapeutics (ORKA) SEC Filings & 10K Form

Oruka Therapeutics logo
$15.27 -0.29 (-1.86%)
Closing price 09/24/2025 04:00 PM Eastern
Extended Trading
$15.65 +0.38 (+2.46%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Oruka Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
09/19/2025
5:56 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SCHEDULE 13D/A
09/19/2025
4:33 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2025
3:29 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 424B3
07/17/2025
7:12 PM		BlackRock, Inc. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SCHEDULE 13G
07/01/2025
8:21 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Sandler Laura Lee (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/01/2025
8:26 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Sandler Laura Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:30 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Co-Invest III L.P. (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
7:00 AM		Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G
03/11/2025
11:15 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
03/10/2025
6:00 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SCHEDULE 13D/A
03/06/2025
4:17 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form POS AM
02/27/2025
5:42 PM		Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/27/2025
5:42 PM		Koh Bong Y (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Shah Nimish P (Reporting)
Venrock Healthcare Capital Partners EG, L.P. (Reporting)
Venrock Healthcare Capital Partners III, L.P. (Reporting)
VHCP Co-Investment Holdings III, LLC (Reporting)
VHCP Management EG, LLC (Reporting)
VHCP Management III, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
5:43 PM		Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SCHEDULE 13G/A
02/05/2025
3:00 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2025
3:44 PM		Agarwal Arjun (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:41 PM		Klein Lawrence Otto (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:42 PM		Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Quinlan Paul T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2025
3:43 PM		Goncalves Joana (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
6:16 AM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
11:15 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form EFFECT
11/21/2024
5:30 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
Oruka Therapeutics, Inc. (Issuer)
Oruka Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
5:30 PM		Fairmount Funds Management LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
11/14/2024
6:38 PM		Avidity Partners Management LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:49 PM		Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:20 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/14/2024
3:56 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
11:04 AM		Allostery Investments LP (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
8:56 AM		JANUS HENDERSON GROUP PLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G/A
11/14/2024
5:37 AM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/13/2024
3:01 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/22/2024
3:15 PM		Adage Capital Management, L.P. (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13D/A
10/18/2024
3:11 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form DEF 14A
10/07/2024
10:37 AM		FMR LLC (Filed by)
Oruka Therapeutics, Inc. (Subject)
Oruka Therapeutics (Subject)
Form SC 13G
10/04/2024
3:05 PM		Oruka Therapeutics, Inc. (Filer)
Oruka Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ORKA) was last updated on 9/25/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsoredtc pixel
He Called Nvidia at $1.10. Now, He Says THIS Stock Will…
The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...
The Oxford Club | Sponsoredtc pixel
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Capital Gains Tax Strategies for Seniors
Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...
SmartAsset | Sponsoredtc pixel
A New Way to Double Your Retirement Income?
Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...
Investors Alley | Sponsoredtc pixel
Strange crypto pattern discovered by 40-person research team
Something unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...
Crypto Swap Profits | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel